DBT Skills Training for Patients with Metastatic Lung Cancer
LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living With Metastatic Lung Cancer
NA · Duke University · NCT06464562
This study is testing whether teaching emotional skills through Dialectical Behavioral Therapy can help people with metastatic lung cancer feel better and improve their quality of life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Duke University (other) |
| Locations | 1 site (Durham, North Carolina) |
| Trial ID | NCT06464562 on ClinicalTrials.gov |
What this trial studies
This study focuses on providing Dialectical Behavioral Therapy (DBT) Skills Training to patients diagnosed with metastatic lung cancer, who often experience high levels of psychological distress and a poor quality of life. The intervention aims to equip these patients with practical skills to manage their emotional challenges and improve their overall well-being. By teaching techniques such as mindfulness and emotion regulation, the program seeks to help patients navigate the complexities of living with a terminal illness. The study is designed for patients who are currently undergoing treatment with non-curative intent and have reported significant distress.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with metastatic non-small cell lung cancer who are experiencing high psychological distress.
Not a fit: Patients with untreated serious mental illnesses or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life and emotional resilience of patients living with metastatic lung cancer.
How similar studies have performed: While DBT has been effective in other populations, its application in metastatic lung cancer patients is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. be diagnosed with metastatic (AJCC stage IV) non-small cell lung cancer 2. be undergoing lung cancer treatment with non-curative intent 3. endorse \>=3 out of 10 on the NCCN distress thermometer over the past week 4. be \> 18 years of age 5. be able to understand, speak, and read English, and 5) be able to provide informed consent Exclusion Criteria: 1. reported or suspected cognitive impairment 2. presence of untreated serious mental illness (e.g., schizophrenia) indicated by the medical chart or treating oncologist 3. expected survival \<6 months
Where this trial is running
Durham, North Carolina
- Duke University Medical Center — Durham, North Carolina, United States (RECRUITING)
Study contacts
- Study coordinator: Kelly A Hyland, PhD
- Email: kelly.hyland@duke.edu
- Phone: 919 660 2737
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer Metastatic to Lung